Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Alzinova AB | 294,592 | net | 20 Feb 2026 | tx 8+294,592 |
| Lipigon Pharmaceuticals AB | 263,572 | net | 26 Apr 2024 | tx 1+263,572 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 20 Feb 2026 | PURCHASE | Alzinova AB | 12,010 | 2.40 SEK | |
| 20 Feb 2026 | PURCHASE | Alzinova AB | 5,932 | 2.40 SEK | |
| 06 May 2025 | PURCHASE | Alzinova AB | 4,943 | 2.00 SEK | first after silence |
| 03 Apr 2025 | GRANT_AWARD | Alzinova AB | 250,000 | 0.26 SEK | deriv |
| 26 Apr 2024 | PURCHASE | Lipigon Pharmaceuticals AB | 263,572 | 0.06 SEK | derivfirst after silence |
| 04 Apr 2023 | PURCHASE | Alzinova AB | 4,907 | 0.00 SEK | deriv |
| 04 Apr 2023 | OTHER | Alzinova AB | 5,900 | 2.17 SEK | |
| 06 Apr 2023 | OTHER | Alzinova AB | 5,900 | 2.17 SEK | deriv |
2 purchases reported after at least 12 months of silence — most recent on 06 May 2025.